Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

about

Combination chemotherapy with irinotecan and gemcitabine for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancer: a multicenter phase I/II trial (GOGO-Ov 6).

Item

http://www.wikidata.org/entity/Q48617362

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).

@en

Combination chemotherapy with ...... a multicenter phase I/II trial

@nl

type

Item

label

Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).

@en

Combination chemotherapy with ...... a multicenter phase I/II trial

@nl

prefLabel

Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).

@en

Combination chemotherapy with ...... a multicenter phase I/II trial

@nl

P1476

Combination chemotherapy with ...... phase I/II trial (GOGO-Ov 6).

@en

P2093

Akinori Wakimoto

http://www.w3.org/2001/XMLSchema#string

Eiji Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kae Hashimoto

http://www.w3.org/2001/XMLSchema#string

Kazushige Adachi

http://www.w3.org/2001/XMLSchema#string

Kenjiro Sawada

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Yoshino

http://www.w3.org/2001/XMLSchema#string

Masahiko Takemura

http://www.w3.org/2001/XMLSchema#string

Masami Fujita

http://www.w3.org/2001/XMLSchema#string

Ruriko Nakae

http://www.w3.org/2001/XMLSchema#string

Seiji Mabuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.

A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.

Phase II study of combination chemotherapy with gemcitabine and irinotecan in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens.

Overcoming platinum resistance in ovarian carcinoma.

Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines

Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.

Carcinosarcoma of the ovary: a review of the literature.

P2888

s00280-017-3468-5

P304

1239-1247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3468-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29080971

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

phase II clinical trial